Chong Kun Dang Bio gets EDQM certification

Published: 2009-07-29 06:57:00

Updated: 2009-07-29 06:57:00

Chong Kun Dang Bio, an affiliate company of Chong Kun Dang Pharmaceutical Co., said on July 22 it has received a CEP (Certificate of European Pharmacopoeia) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) over cyclosporin, following the certification of acarbose las...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK